
    
      This is a randomized, double-blind, placebo-controlled study, which aimed to evaluate the
      effects of denosumab on erosion healing and change in physical function in rheumatoid
      arthritis (RA) patients in low-disease activity or remission receiving synthetic DMARDs
      (sDMARDs) treatment using High-resolution peripheral quantitative CT (HR-pQCT).
    
  